miércoles, 26 de marzo de 2025

Wave to submit Duchenne drug for approval after Phase 2 success Company says the treatment appears to improve muscle health

https://www.statnews.com/2025/03/26/wave-life-sciences-duchenne-muscular-dystrophy/

No hay comentarios:

Publicar un comentario